Navigation Links
MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
Date:10/9/2007

SAVANNAH, Ga. October 9, 2007 MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus. The PROVECTOR will initially be made available in countries where such diseases are a major threat to the health of the population. MIT intends to distribute the PROVECTOR internationally to licensees through worldwide distribution partnerships.

The PROVECTOR uses visual, olfactory and chemical signals to attract mosquitoes, which ingest anti-malarial and anti-viral treatments that inhibit the development of the pathogens within the mosquito. The two current principal methods of controlling malaria are drug treatment of patients and the application of pesticides, which can both be very expensive, particularly in developing countries. Additionally, increases in drug resistance of the parasite, as well as widespread insecticide resistance in mosquitoes, cause these current methods to be less effective. Preliminary tests of prototypes of the PROVECTOR have indicated a reduction in the dengue viruses and malaria carried by mosquitoes. The Company is continuing to refine its prototypes prior to commercialization.

Dr. Thomas M. Kollars, Jr., Chief Scientific Advisor of MIT Holding and Chief Executive Officer of MEVLABS, commented, The PROVECTOR provides a safe and economical solution to the health threat that mosquitoes carrying infectious disease pose to humans. Malaria currently infects over one hundred million people worldwide and kills at least a million people every year, mostly children. Dengue fever is also currently on the rise worldwide, causing illness in hundreds of thousands of people. Dengue cases have also been reported on the border of the Uni
'/>"/>

Contact: Janet Vasquez
janet@investorrelationsgroup.com
212-825-3210
MIT Holding/Mevlabs
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Georgia Tech accelerates drug discovery with new IBM supercomputing cluster
2. Scientists journey to southern Africa to unravel the secret world of elephant communication
3. New Species of Coral Discovered Off Southern California
4. High carbon dioxide levels spur Southern pines to grow more needles
5. Genetically modified maize not found in southern Mexico
6. Oldest dated evidence of cattle in southern Africa found
7. High levels of blindness in southern Sudan following years of war
8. Massive herds of animals found to still exist in Southern Sudan
9. New, automated tool successfully classifies and relates proteins in unprecedented way
10. Biomarkers isolated from saliva successfully predict oral and breast cancer
11. UN successfully tests green pesticide against locusts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Consumer Reports Health News August 2009 55382 1Consumer Reports Health News August 2009 55382 2Consumer Reports Health News August 2009 55382 3Consumer Reports Health News August 2009 55382 4Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 1Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 1Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 3Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 4
...entists have identified one of the genes implicate...mmon cause of blindness in developed countries. , ...et , adds to the growing understanding of the gene...ich the researchers believe should ultimately lead...o-thirds of people aged 80 years or older are affe...
...versity of Iowa researchers and colleagues in Fran...tentially fatal human heart rhythm disorder called...drome," the disease affects approximately one in 6... for 50 percent or more of the permanent pacemaker...wly discovered gene variant is rare, the study pro...
... atomic-resolution view of an enzyme found only in...f Washington (UW) clues about how this enzyme, ess...odiesterase 6 (PDE6), is central to the way light ... signals to the brain. , This particular form of...the retina and has not been well-researched, in co...
Other Biology News:Genetic finding implicates innate immune system in major cause of blindness 2Study provides insight on a common heart rhythm disorder 2Study provides insight on a common heart rhythm disorder 3Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye 2
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...N.J. and EMERYVILLE, Calif., May 14 Bayer HealthC..., Inc. (Nasdaq: ONXX ) today announced that more...(sorafenib) tablets will be presented at the 2009 ...l meeting. , , "Nexavar has a proven track record... hepatocellular carcinoma (HCC), or liver cancer, ...
..., May 14 ANY LAB TEST NOW(R), the first retail di...ations nationwide, has partnered with Atherotech, ...to provide the VAP(R) Cholesterol Test direct to c...ol Test is an expanded cholesterol profile that id... the first cholesterol test to directly measure LD...
...LE, Md., May 14 Vanda Pharmaceuticals Inc. (Nasda...osters on its newly approved atypical antipsychoti... Psychiatric Association (APA) annual meeting in S... for the acute treatment of schizophrenia in adult...teon at APA. Tasimelteon is an investigational co...
Other Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 2Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 4
SURE E. coli Strain from Stratagene
21-mer duplex from B-Bridge International
...dy to CRF The antibody blocks specificially with ... Cells and fibres are found in the paraventricular...reated 4% FA perfused tissue. Immunogen: CRF: ...s-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-...
JM101 E. coli Strain from Stratagene
Biology Products: